Overview

Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare dosing compliance between study patients taking controlled release carvedilol once a day, and study patients taking immediate release carvedilol (Coreg) twice a day.
Phase:
Phase 3
Details
Lead Sponsor:
Cardiovascular Clinical Studies
Collaborator:
GlaxoSmithKline
Treatments:
Carvedilol